They are developing computational approaches to analyze genome and transcriptome sequencing data and developing high-throughput experimental approaches to characterize the functional impact of cancer variants. Dr. Brooks received her Ph.D. in molecular and cell biology with a designated emphasis in computational and genomic biology at UC Berkeley with Dr. Steven Brenner, then was a postdoctoral fellow at the Dana-Farber Cancer Institute and the Broad Institute in the laboratory of Dr. Matthew Meyerson. In recognition of her work, Dr. Brooks was named a Damon Runyon Cancer Research Foundation Merck Fellow and also received the Dale F. Frey Award for Breakthrough Scientists.